Federal Register / Vol. 76, No. 77 / Thursday, April 21, 2011 / Notices 22399 

please contact Judy Sparrow at least 

seven (7) days in advance of the 

meeting. 

ONC is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://healthit.hhs.gov for procedures 

on public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act 

(Pub. L. 92–463, 5 U.S.C., App. 2). 

Dated: April 12, 2011. 

Judith Sparrow, 

Office of Programs and Coordination, Office 

of the National Coordinator for Health 

Information Technology. 

[FR Doc. 2011–9691 Filed 4–20–11; 8:45 am] 

BILLING CODE 4150–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

HIT Policy Committee’s Workgroup 

Meetings; Notice of Meetings 

AGENCY: Office of the National 

Coordinator for Health Information 

Technology, HHS. 

ACTION: Notice of meetings. 

This notice announces forthcoming 

subcommittee meetings of a Federal 

advisory committee of the Office of the 

National Coordinator for Health 

Information Technology (ONC). The 

meetings will be open to the public via 

dial-in access only. 

Name of Committees: HIT Policy 

Committee’s Workgroups: Meaningful 

Use, Privacy & Security Tiger Team, 

Quality Measures, Governance, 

Adoption/Certification, and Information 

Exchange workgroups. 

General Function of the Committee: 

To provide recommendations to the 

National Coordinator on a policy 

framework for the development and 

adoption of a nationwide health 

information technology infrastructure 

that permits the electronic exchange and 

use of health information as is 

consistent with the Federal Health IT 

Strategic Plan and that includes 

recommendations on the areas in which 

standards, implementation 

specifications, and certification criteria 

are needed. 

Date and Time: The HIT Policy 

Committee Workgroups will hold the 

following public meetings during May 

2011: May 2nd Meaningful Use 

Workgroup, 

9 a.m. to 11 a.m./ET; May 3rd 

Meaningful Use Workgroup in-person 

meeting, location—TBD, 9 a.m. to 3 

p.m./ET; May 4th Privacy & Security 

Tiger Team, 

2 p.m. to 4 p.m./ET; May 5th Quality 

Measures Workgroup, 10 a.m. to 11:30 

a.m./ET; May 10th Meaningful Use 

Workgroup, 9 a.m. to 12 p.m./ET; May 

13th Meaningful Use Workgroup 

hearing, location—TBD, 9 a.m. to 3 

p.m./ET; May 16th Privacy & Security 

Tiger Team, 2 p.m. to 4 p.m./ET; May 

19th Quality Measures Workgroup 

hearing, location—TBD, 9 a.m. to 3 

p.m./ET; and May 20th Meaningful Use 

Workgroup, 10 a.m. to 1 p.m./ET. 

Location: All workgroup meetings 

will be available via webcast; for 

instructions on how to listen via 

telephone or Web visit http:// 

healthit.hhs.gov. Please check the ONC 

Web site for additional information or 

revised schedules as it becomes 

available. 

Contact Person: Judy Sparrow, Office 

of the National Coordinator, HHS, 330 C 

Street, SW., Washington, DC 20201, 

202–205–4528, Fax: 202–690–6079, email: judy.sparrow@hhs.gov. Please call 

the contact person for up-to-date 

information on these meetings. A notice 

in the Federal Register about last 

minute modifications that affect a 

previously announced advisory 

committee meeting cannot always be 

published quickly enough to provide 

timely notice. 

Agenda: The workgroups will be 

discussing issues related to their 

specific subject matter, e.g., meaningful 

use, information exchange, privacy and 

security, quality measures, governance, 

or adoption/certification. If background 

materials are associated with the 

workgroup meetings, they will be 

posted on ONC’s Web site prior to the 

meeting at http://healthit.hhs.gov. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the workgroups. Written 

submissions may be made to the contact 

person on or before two days prior to 

the workgroup’s meeting date. Oral 

comments from the public will be 

scheduled at the conclusion of each 

workgroup meeting. Time allotted for 

each presentation will be limited to 

three minutes. If the number of speakers 

requesting to comment is greater than 

can be reasonably accommodated 

during the scheduled open public 

session, ONC will take written 

comments after the meeting until close 

of business on that day. 

If you require special 

accommodations due to a disability, 

please contact Judy Sparrow at least 

seven (7) days in advance of the 

meeting. 

ONC is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://healthit.hhs.gov for procedures 

on public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act 

(Pub. L. 92–463, 5 U.S.C., App. 2). 

Dated: April 12, 2011. 

Judith Sparrow, 

Office of Programs and Coordination, Office 

of the National Coordinator for Health 

Information Technology. 

[FR Doc. 2011–9694 Filed 4–20–11; 8:45 am] 

BILLING CODE 4150–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-11–0773] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Daniel Holcomb, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS–D74, Atlanta, GA 30333 or 

send an e-mail to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

National Surveillance for Severe 

Adverse Events Associated with 

Treatment of Latent Tuberculosis 

Infection—(0920–0773 exp. 04/31/ 

2011)—Reinstatement with change— 

Division of Tuberculosis Elimination 

(DTBE), National Center for HIV, Viral 


emcdonald on DSK2BSOYB1PROD with NOTICES
22400 Federal Register / Vol. 76, No. 77 / Thursday, April 21, 2011 / Notices 

Hepatitis, STD, and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

As part of the national tuberculosis 

(TB) elimination strategy, the American 

Thoracic Society and CDC have 

published recommendations for targeted 

testing for TB and treatment for latent 

TB infection (LTBI)(Morbidity and 

Mortality Weekly Report 

2000;49[RR06];1–54). However, between 

October 2000 and September 2004, the 

CDC received reports of 50 patients with 

severe adverse events (SAEs) associated 

with the use of the two or three-month 

regimen of rifampin and pyrazinamide 

(RZ) for the treatment of LTBI; 12 (24%) 

patients died (Morbidity and Mortality 

Weekly Report 2003;52[31]:735–9). In 

2004, CDC began collecting reports of 

SAEs associated with any treatment 

regimen for LTBI. For surveillance 

purposes, an SAE was defined as any 

drug-associated reaction resulting in a 

patient’s hospitalization or death after at 

least one treatment dose for LTBI. 

During 2004¥2008, CDC received 17 

reports of SAEs in 15 adults and two 

children; all patients had received 

isoniazid (INH) and had experienced 

severe liver injury (Morbidity and 

Mortality Weekly Report 2010; 

59:224–9). 

Reports of SAEs related to RZ and 

INH have prompted a need for this 

project—a national surveillance system 

of such events. The objective of the 

project is to determine the annual 

number and temporal trends of SAEs 

associated with any treatment for LTBI 

in the United States. Surveillance of 

such events will provide data to support 

periodic evaluation of guidelines for 

treatment of persons with LTBI and 

revision. 

The Centers for Disease Control and 

Prevention request approval for a 3-year 

reinstatement with change of the 

previously approved National 

Surveillance for Severe Adverse Events 

Associated with Treatment of Latent 

Tuberculosis Infection—(OMB No. 

0920–0773, expires April 31, 2011). The 

changes include a shortened data 

collection form and an increase in the 

number of respondents. This project 

will continue the passive reporting 

system for SAEs associated with therapy 

for LTBI. The system will rely on 

medical chart review and/or onsite 

investigations by TB control staff. 

Potential respondents are any of the 

60 reporting areas for the national TB 

surveillance system (the 50 states, the 

District of Columbia, New York City, 

Puerto Rico, and 7 jurisdictions in the 

Pacific and Caribbean). Data will be 

collected using the data collection form 

for SAEs associated with LTBI 

treatment. Based on previous reporting, 

CDC anticipates receiving an average of 

10 responses per year from the 60 

reporting areas. The data collection form 

is completed by healthcare providers 

and health departments for each 

reported hospitalization or death related 

to treatment of LTBI and contains 

demographic, clinical, and laboratory 

information. CDC will analyze and 

periodically publish reports 

summarizing national LTBI treatment 

adverse events statistics and also will 

conduct special analyses for publication 

in peer-reviewed scientific journals to 

further describe and interpret these 

data. 

The Food and Drug Administration 

(FDA) collects data on adverse events 

related to drugs through the FDA 

MedWatch Program. CDC is 

collaborating with FDA in the reporting 

of SAEs. Reporting will be conducted 

through telephone, e-mail, or during 

CDC site visits. In this request, CDC is 

requesting approval for approximately 

60 burden hours annually, an estimated 

increase of 36 hours. This is due to an 

estimated increase of reports of SAEs 

after the publication of the MMWR 

report on SAEs in 2010. There are no 

costs to respondents other than their 

time. 

ESTIMATE OF ANNUALIZED BURDEN TABLE

Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Physicians ........................................................................................................ 10 1 1 10 

Nurses .............................................................................................................. 10 1 4 40 

Medical Clerk ................................................................................................... 10 1 1 10 

Total .......................................................................................................... ........................ ........................ ........................ 60 

Daniel Holcomb, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2011–9671 Filed 4–20–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day-11–0792] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Daniel Holcomb, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS–D74, Atlanta, GA 30333 or 

send an e-mail to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; 

(c) ways to enhance the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Environmental Health Specialists 

Network (EHS–Net) National Voluntary 

Environmental Assessment Information 

System (NVEAIS)—New—National 

Center for Environmental Health 


emcdonald on DSK2BSOYB1PROD with NOTICES